Joint arthroplasty involves replacement of damaged joint with a prosthetic one. Artificial joints are used to correct abnormalities in the damaged part and restore the functionality of the joint. Artificial joints can be made of ceramic, titanium, alloy, or oxinium and inserted into the body based on the surgeon's expertise, patient's preferences, and the viability of the procedure.
Adroit Market Research study on the global market for artificial joints offers a holistic view of the industry from 2020 to 2028 as forecast period, including factors such as market drivers, limitations, opportunities, threats and regulatory overview. The market has been analyzed from 2018 to 2028, with a base year estimate of 2019 and a projection from 2020 to 2028. The report covers the current status and potential characteristics of the market at both the global and the country level. Moreover, the report also assesses market competition with Porter's analysis of five strengths and places leading players on the basis of their product range, regional presence, strategic initiatives and overall sales. Prominent players in the global artificial joints market have been analyzed in depth.
The need for artificial joints is rising immensely owing to high prevalence of degenerative disorders across the globe coupled with rising geriatric population susceptible to these degenerative disorders. Joint diseases such as arthrosis and arthritis develop in 90% of the population aged 55 years and above. These disease are accompanied by joint deformities, degradation of cartilage and persistent pain leading to limited mobility and deteriorated quality of life of patients. All these factors will accelerate the demand for artificial joints during the forecast period.
By material, the global artificial joints market is segregated into ceramics, alloys, oxinium, and others. Strong biocompatibility, excellent abrasion properties and ability to promote bone formation in bone defects will drive the demand for bioactive ceramics over the coming few years.
North America is expected to hold substantial share of the global artificial joints market owing to increase in prevalence of osteoarthritis in the U.S. and Canada. For instance, more than 20 million Americans are suffering from osteoarthritis. Moreover, presence of well-established players, healthcare infrastructure, and skilled healthcare professionals in the region is further expected to augment the growth of the market over the coming years.
Asia Pacific is expected to witness a lucrative growth during the forecast period owing increase in prevalence of joint disorders along with presence of large geriatric population in emerging countries such as India and China.
- key players operating in the global artificial joints market include Depuy Synthes, Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew, Aesculap AG, Arthrex, Inc., JRI Orthopedics, DJO Global, Inc., Globus Medical, and Exatech, Inc.
Key Segments of the Global Artificial Joints Market
Material Overview, 2018-2028 (USD Million)
Application Overview, 2018-2028 (USD Million)
- Artificial Joints of Knee
- Artificial Joints of Hip
- Artificial Joints of Shoulders
Regional Overview, 2018-2028 (USD Million)
- North America
- United Kingdom
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa